103291-07-2

Basic information

• Product Name: 2-Fluoro-5-bromoanisole
• Synonyms: 2-fluoro-5-bromoanisole;2-FLUORO-5-BROMO ANISOLE,=98%;4-Bromo-1-fluoro-2-methoxybenzene;4-Bromo-1-fluoro-2-methoxybenzene, 5-Bromo-2-fluorophenyl methyl ether;Benzene,4-broMo-1-fluoro-2-Methoxy;2-fluoro-bromoanisole
• CAS NO: 103291-07-2
• Molecular Formula: C₇H₆BrFO
• Molecular Weight: 205.02
• Product Categories: Fluorine series
• Mol File: 103291-07-2.mol

Chemical Properties

• Boiling Point: 205.786 °C at 760 mmHg
• Flash Point: 92.476 °C
• Appearance: /Liquid
• Density: 1.532 g/cm³
• Vapor Pressure: 0.352mmHg at 25°C
• Refractive Index: 1.519
• Storage Temp.: Room temperature.
• CAS DataBase Reference: 2-Fluoro-5-bromoanisole(CAS DataBase Reference)
• NIST Chemistry Reference: 2-Fluoro-5-bromoanisole(103291-07-2)
• EPA Substance Registry System: 2-Fluoro-5-bromoanisole(103291-07-2)

Safety Data

• Hazard Codes: Xn
• Statements: 22-36-52
• Safety Statements: 26
• WGK Germany: 3
• HazardClass: IRRITANT
• Hazardous Substances Data: 103291-07-2(Hazardous Substances Data)

Usage

Chemical Properties

Pale yellow liquid

InChI:InChI=1/C7H6BrFO/c1-10-7-4-5(8)2-3-6(7)9/h2-4H,1H3

Upstream product

• 112204-58-7 5-Bromo-2-fluorophenol 
• 74-88-4 methyl iodide 
• 64465-53-8 4-fluoro-3-methoxyaniline 
• 77-78-1 dimethyl sulfate 
• 348-61-8 1-bromo-3,4-difluorobenzene 
• 124-41-4 sodium methylate 

Downstream Products

• 425378-85-4 2-(4-fluoro-3-methoxyphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane 
• 112204-58-7 5-Bromo-2-fluorophenol 
• 854778-31-7 4-fluoro-3-methoxyphenylboronic acid 
• 936092-73-8 (2-chloro-5-methyl-pyrimidin-4-yl)-(4-fluoro-3-methoxy-phenyl)-amine 
• 1035219-86-3 3-(4-bromo-2-methoxyphenoxy)azetidine-1-carboxylic acid tert-butyl ester 
• 1227163-14-5 1-(3-bromophenyl)-4-fluoro-1-(4-fluoro-3-methoxyphenyl)-1H-isoindol-3-amine 
• 1239963-89-3 methyl 2-(4-fluoro-3-methoxyphenyl)-2-methylpropanoate 
• 1239963-90-6 2-(4-fluoro-3-methoxyphenyl)-2-methylpropanoic acid 
• 1239963-91-7 2-(4-fluoro-3-methoxyphenyl)-N-methoxy-N,2-dimethylpropanamide 
• 1239963-92-8 3-(4-fluoro-3-methoxyphenyl)-3-methylbutan-2-one 
• 1239963-93-9 1-bromo-3-(4-fluoro-3-methoxyphenyl)-3-methylbutan-2-one 
• 1239963-94-0 1-azido-3-(4-fluoro-3-methoxyphenyl)-3-methylbutan-2-one 
• 1239963-95-1 1-amino-3-(4-fluoro-3-methoxyphenyl)-3-methylbutan-2-one hydrochloride 
• 1239963-96-2 1-(3-(4-fluoro-3-methoxyphenyl)-3-methyl-2-oxobutyl)-3-(4-fluorophenyl)thiourea 

Relevant articles and documents

Active Molybdenum-Based Anode for Dehydrogenative Coupling Reactions

A new and powerful active anode system that can be operated in 1,1,1,3,3,3-hexafluoro-2-propanol (HFIP) has been discovered. In HFIP the molybdenum anode forms a compact, conductive, and electroactive layer of higher-valent molybdenum species. This system can replace powerful but stoichiometrically required MoV reagents for the dehydrogenative coupling of aryls. This electrolytic reaction is more sustainable and allows the conversion of a broad scope of activated arenes.

Preparation method of 3-methoxy-4-fluorobenzaldehyde

The invention discloses a preparation method of 3-methoxy-4-fluorobenzaldehyde. The method comprises the following steps: (1) reacting 3,4-difluorobromobenzene serving as a starting raw material withsodium methoxide to generate a compound III; and (2) reacting the compound III with magnesium to generate a Grignard reagent, and reacting under the condition of N,N-dimethylformamide to generate a compound I, wherein the obtained product is the 3-methoxy-4-fluorobenzaldehyde. The preparation method provided by the invention is higher in yield.

POLYCYCLIC PYRAZOLINONE DERIVATIVE AND HERBICIDE COMPRISING SAME AS EFFECTIVE COMPONENT THEREOF

Provided are a polycyclic pyrazolinone derivative indicated by general formula (1) (in the formula, R1, X1, X2, X3, and Y indicate the definitions provided in the Specification) and a herbicide comprising same as effective component thereof.

BENZAMIDE FACTOR VIIA INHIBITORS USEFUL AS ANTICOAGULANTS

The present invention provides novel benzamide derivatives of Formula (I): or a stereoisomer, tautomer, pharmaceutically acceptable salt, solvate, or prodrug thereof, wherein the variables A, W, Y, Z, R8, and R9 are as defined herein. These compounds are selective inhibitors of factor VIIa which can be used as medicaments.

NEW COMPOUNDS

This invention relates to novel compounds having the structural formula I below: and to their pharmaceutically acceptable salt, compositions and methods of use. These novel compounds provide a treatment or prophylaxis of cognitive impairment, Alzheimer Disease, neurodegeneration and dementia.

AMINO-IMIDAZOLONES AND THEIR USE AS A MEDICAMENT FOR TREATING COGNITIVE IMPAIRMENT, ALZHEIMER DISEASE, NEURODEGENERATION AND DEMENTIA

This invention relates to novel compounds having the structural formula I below: and to their pharmaceutically acceptable salt, compositions and methods of use. These novel compounds provide a treatment or prophylaxis of cognitive impairment, Alzheimer Di

AMINO-IMIDAZOLONES AND THEIR USE AS A MEDICAMENT FOR TREATING COGNITIVE IMPAIRMENT, ALZHEIMER DISEASE, NEURODEGENERATION AND DEMENTIA

This invention relates to novel compounds having the structural formula (I) and to their pharmaceutically acceptable salt, compositions and methods of use. These novel compounds provide a treatment or prophylaxis of cognitive impairment, Alzheimer Disease, neurodegeneration and dementia.

New Compounds 319

This invention relates to novel compounds having the structural formula I below: and to their pharmaceutically acceptable salt, compositions and methods of use. These novel compounds provide a treatment or prophylaxis of cognitive impairment, Alzheimer Disease, neurodegeneration and dementia.

Phenylglycinamide and pyridylglycinamide derivatives useful as anticoagulants

The present invention provides novel phenylglycinamide derivatives of Formula (I) or (IV): or a stereoisomer, tautomer, pharmaceutically acceptable salt, solvate, or prodrug thereof, wherein the variables W, W1, Y, Z, R7, R8, R9, and R11 are as defined herein. These compounds are selective inhibitors of factor VIIa which can be used as medicaments.

PHENYLGLYCINAMIDE DERIVATIVES USEFUL AS ANTICOAGULANTS

The present invention relates generally to phenylglycinamide derivatives that inhibit serine proteases. In particular it is directed to novel phenylglycinamide derivatives, and analogues thereof, which are useful as selective inhibitors of serine protease enzymes of the coagulation cascade; for example thrombin, factor VIIa, factor Xa, factor XIa, factor IXa, and/or plasma kallikrein. In particular, it relates to compounds that are factor VIIa inhibitors. This invention also relates to pharmaceutical compositions comprising these compounds and methods of using the same.